They also reported that the protein expression of Beclin 1 was not significantly associated with clinicopathological parameters, including patient age, gender, tumor size, primary site, tumor differentiation, TNM stage, and lymph node metastasis 20. Here, BECN1 is linked to metastatic malignant neoplasm in the lymph nodes.